Health Economics

As China's elderly population continues to grow, the nation faces a looming crisis in dementia care that demands immediate attention. With informal care still...

Poland's battle with COVID-19 left an indelible mark on its demographic and economic landscape, with significant workforce implications. As the pandemic wreaked havoc globally,...

The complexities of dealing with chronic Chagas disease (CCD) in Latin America extend beyond health, with communities grappling with significant economic challenges. Though the...

Germany's Joint Federal Committee (G-BA) made a landmark decision on December 18, 2025, emphasizing the regulation of pharmaceutical pricing and reimbursement. The committee set...

A pivotal decision by Germany's Joint Federal Committee (G-BA) on January 13, 2026, revised the known annual therapy costs associated with Mirikizumab, particularly for...

Gene therapy holds great promise for treating hemophilia, offering potential long-term solutions to those with hemophilia A and B. Yet, addressing its financial and...

As the year 2026 unfolds, the German Federal Joint Committee (G-BA) has embarked on a critical mission to reassess the cost implications of treating...

In a recent development that holds significance for pharmaceutical vigilance across Europe, the European Medicines Agency (EMA) has undertaken a comprehensive review of the...

Access to groundbreaking therapies for metastatic hormone-sensitive prostate cancer (mHSPC) remains unequal despite healthcare advances. A comprehensive study conducted in Ontario, Canada, seeks to...

In a transformative decision aimed at improving healthcare access for individuals with rare disorders, Pharmac announced it would fund the treatment nitisinone for patients...

The pharmaceutical landscape for ulcerative colitis (UC) treatment undergoes a significant realignment as the Joint Federal Committee (G-BA) issues an essential amendment affecting therapeutic...

China's healthcare system stands at a crucial crossroads with the introduction of integrating sugemalimab and chemotherapy (S + C) for treating advanced gastric or...

Navigating the intricate landscape of medication management in older adults necessitates a delicate balance between clinical advice and personal beliefs. As individuals age, their...

In a significant stride towards making healthcare more affordable in the United States, AbbVie has entered into a landmark agreement with the Trump administration....

Brucellosis continues to pose significant challenges to public health and the economy in Iran. Despite its critical impact, efforts to tackle the disease suffer...